Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis

BACKGROUND: The objective of this study was to evaluate the efficacy and safety of repeated low-dose rituximab treatment guided by monitoring circulating CD19+ B cells in patients with refractory myasthenia gravis (MG). METHODS: Patients with refractory MG who had received rituximab treatment at two...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Kyomin, Hong, Yoon-Ho, Ahn, So-Hyun, Baek, Seol-Hee, Kim, Jun-Soon, Shin, Je-Young, Sung, Jung-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751534/
https://www.ncbi.nlm.nih.gov/pubmed/31555344
http://dx.doi.org/10.1177/1756286419871187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751534/
https://www.ncbi.nlm.nih.gov/pubmed/31555344
http://dx.doi.org/10.1177/1756286419871187

Ejemplares similares